About this trial
This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years of age and older
Ability to understand study assessments and give informed consent to data collection
Ability to comply with the study protocol
Ability to understand and respond to instructions in English
Disqualifiers
Allergy to adhesive used in biosensor patch
Life-threatening disease process outside of area under study, such as actively treated cancer or being actively considered for organ pre-transplant (such as hepatic failure; end-stage renal disease).
Severe CVD defined by hospital admission for cardiac diagnosis within 30 days of enrollment or documentation of NYHA functional class IV
-- For participants who do not qualify due to this exclusion, and have not been hospitalized within 30 days of enrollment, they may reapply to enroll in the study
Trial population
Participants who have been diagnosed including but not limited to the following Cardiovascular Disease types: Aortic Stenosis, Heart Failure, Hypertension Obstructive Cardiomyopathy, Dilated Cardiomyopathy
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Longitudinal Assessment of Clinical Status
Measured by Heart Rate (beats per minute)
Longitudinal Assessment of Clinical Status
Heart Rate Variability (per millisecond)
Longitudinal Assessment of Clinical Status
percentage of Atrial Fibrillation Burden (duration of time per day of demonstrated AF)
Longitudinal Assessment of Clinical Status
Breaths per minute